6PSA
PIE12 D-PEPTIDE AGAINST HIV ENTRY (IN COMPLEX WITH IQN17 Q577R RESISTANCE MUTANT)
6PSA の概要
エントリーDOI | 10.2210/pdb6psa/pdb |
分子名称 | PIE12 D-peptide, IQN17, CHLORIDE ION, ... (4 entities in total) |
機能のキーワード | hiv, helix, hiv entry inhibitor, iqn17 pie12, d-peptide inhibitor, viral protein-inhibitor complex, viral protein/inhibitor |
由来する生物種 | synthetic construct 詳細 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 7642.74 |
構造登録者 | |
主引用文献 | Smith, A.R.,Weinstock, M.T.,Siglin, A.E.,Whitby, F.G.,Francis, J.N.,Hill, C.P.,Eckert, D.M.,Root, M.J.,Kay, M.S. Characterization of resistance to a potent D-peptide HIV entry inhibitor. Retrovirology, 16:28-28, 2019 Cited by PubMed Abstract: PIE12-trimer is a highly potent D-peptide HIV-1 entry inhibitor that broadly targets group M isolates. It specifically binds the three identical conserved hydrophobic pockets at the base of the gp41 N-trimer with sub-femtomolar affinity. This extremely high affinity for the transiently exposed gp41 trimer provides a reserve of binding energy (resistance capacitor) to prevent the viral resistance pathway of stepwise accumulation of modest affinity-disrupting mutations. Such modest mutations would not affect PIE12-trimer potency and therefore not confer a selective advantage. Viral passaging in the presence of escalating PIE12-trimer concentrations ultimately selected for PIE12-trimer resistant populations, but required an extremely extended timeframe (> 1 year) in comparison to other entry inhibitors. Eventually, HIV developed resistance to PIE12-trimer by mutating Q577 in the gp41 pocket. PubMed: 31640718DOI: 10.1186/s12977-019-0489-7 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.3 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード